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The cGMP-dependent protein kinase (PKG) serves as
an integral component of second messenger sig-
naling in a number of biological contexts including
cell differentiation, memory, and vasodilation. PKG
is homodimeric and large conformational changes
accompany cGMP binding. However, the structure
of PKG and the molecular mechanisms associated
with protomer communication following cGMP-
induced activation remain unknown. Here, we report
the 2.5 A˚ crystal structure of a regulatory domain
construct (aa 78–355) containing both cGMP binding
sitesofPKG Ia. Adistinctandsegregatedarchitecture
with an extended central helix separates the two
cGMPbindingdomains. Additionally, a previously un-
characterized helical domain (switch helix) promotes
the formation of a hydrophobic interface between
protomers. Mutational disruption of this interaction
in full-length PKG implicates the switch helix as a crit-
ical site of dimer communication in PKG biology.
These results offer new structural insight into the
mechanism of allosteric PKG activation.
INTRODUCTION
As key members of the AGC family of protein kinases, all
mammalian PKG isoforms (Ia, Ib, II) share a similar domain con-
figuration (Figure 1A). At their N termini, coiled coils promote a
parallel homodimeric configuration, followed by an autoinhibi-
tory domain (AI) and two tandem cyclic nucleotide (cNT) binding
sites, which cooperatively regulate C-terminal catalytic activity
(for review, see Francis and Corbin, 1994; Hofmann et al., 2009;
Pfeifer et al., 1999; Vaandrager et al., 2005). The current model of
PKG Ia holoenzyme assembly and mechanism of activationStructure 19, 1317–13stresses the importance of the AI domain (aa 64–78) within
the N-terminal region (Heil et al., 1987; Wolfe et al., 1989). This
flexible hinge segment has a pseudo-substrate sequence and
is believed to autoinhibit the C-terminal catalytic center in the
enzyme’s dormant state (Kennelly and Krebs, 1991; Landgraf
and Hofmann, 1989; Ruth et al., 1991). Autophosphorylation at
various N-terminal residues appears to weaken this intramolec-
ular inhibitory interaction; however, only cGMP binding to both
the A- and B-domains induces the conformational change
necessary for full kinase activity (Aitken et al., 1984; Chu et al.,
1997; Francis et al., 2002). Although it is believed that the dimer
stays intact upon cGMP-induced activation, the overall con-
formational change is substantial (Alverdi et al., 2008; Richie-
Jannetta et al., 2006; Zhao et al., 1997). A significant molecular
elongation centered about both the N-terminal dimerization
domain (D/D) as well as the C-terminal catalytic domain accom-
panies cGMP-induced activation. It is at this level of allosteric
modulation that underscores the most distinct difference
between PKG and the cAMP-dependent protein kinase (PKA).
While the regulatory and catalytic subunits of PKA dissociate
upon cyclic nucleotide-induced activation (Gill and Garren,
1971), PKG harbors these components on the same polypeptide
chain (Sandberg et al., 1989; Takio et al., 1984; Wernet et al.,
1989). Another notable difference for all cyclic nucleotide
kinases is their distinct structural order of high and low affinity
cyclic nucleotide binding. For PKG I, the high affinity cyclic
nucleotide sites are closer to the N termini, whereas for PKA I,
PKA II and PKG II, the order of high and low nucleotide binding
affinity sites is reversed (Reed et al., 1996). These structural
differences suggest different means of activation by cyclic
nucleotides and a comprehensive understanding of the mecha-
nisms underlying cGMP-mediated PKG activation will invariantly
require high-resolution biophysical studies.
To better understand the molecular details of PKG regulation,
we solved the 2.5 A˚ crystal structure of a regulatory domain frag-
ment of PKG Ia thought to be central for conveying allosteric
modulation within the enzyme. The structure (amino acid resi-
dues 78–355) presents both tandem cGMP-binding domains27, September 7, 2011 ª2011 Elsevier Ltd All rights reserved 1317
Figure 1. PKG Ia: Domain Organization and
General Architecture of PKG78-355
(A) D/D: docking and dimerization domain; AI: auto-
inhibitory domain; cGMP-A/B: cGMP binding sites A and
B; SW: switch helix. Red bars at the N terminus indicate
site of parallel homodimerization.
(B) Overall fold of PKG78-355 (color coding same as above).
See also Figure S1.
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Crystal Structure of PKG Regulatory Domainand identifies a novel helical subdomain (switch helix, SW) that
follows cGMP-binding site B (Figure 1B). The A-site is cAMP-
bound and confirms a previously suggested disulfide bond
between Cys117 and Cys195. The B-domain is not cNT-occupied,
but rather stabilized by hydrophobic contacts with the SW from
the other protein molecule in the asymmetric unit. This hydro-
phobic interaction highlights an unexpected natural interface,
disruption of which alters the kinetic profile of full-length PKG
Ia. Therefore, the PKG78-355 structure expands our under-
standing of the landscape of PKG domain assembly and sheds
new light on the molecular mechanism of holoenzyme formation
and activation of PKG Ia.
RESULTS AND DISCUSSION
The greatest structural distinction between the two major cyclic
nucleotide regulated protein kinases, PKA and PKG, is the fact
that PKG maintains both its regulatory and catalytic elements
on the same polypeptide chain (Gill et al., 1977), while PKA is
divided into subunits (Gill and Garren, 1971). To better under-
stand how these molecular differences contribute to the unique
characteristics of each kinase, we crystallized the central portion
of the regulatory domain of PKG Ia. While prokaryotic expression
of PKG constructs containing the catalytic domain yields inac-
tive, misfolded protein that is sequestered to inclusion bodies
(Feil et al., 1993), previous attempts to crystallize full-length
PKG from mammalian systems have been unsuccessful as
well. This is in part due to conformational heterogeneity stem-
ming from mixed phosphorylation states at the N terminus and
a proteolytically exposed hinge at Arg77 (Aitken et al., 1984;
Heil et al., 1987; Scholten et al., 2007). We hypothesized that
exclusion of both the N-terminal D/D domain, as well as the
C-terminal catalytic domain would give rise to a stable, mono-1318 Structure 19, 1317–1327, September 7, 2011 ª2011 Elsevier Ltd All rights reservmeric fragment that is readily expressed in
Escherichia coli. Multiple regulatory fragments
were designed to encompass both tandem
cGMP-binding domains (PKG78-326, PKG78-341,
and PKG78-355). The standard method for purifi-
cation of recombinant PKG utilizes cyclic nucle-
otide affinity chromatography which saturates
the allosteric binding sites through an elution
with high concentrations of cNT (Dostmann
et al., 1999). To prevent this artificial exposure
of PKG protein to cNTs, PKG constructs were
engineered with N-terminal hexa-histidine tags
and purified using standard immobilized metal
affinity chromatography (IMAC) methods. We
made three PKG regulatory domain constructs
(PKG78-326, PKG78-341, and PKG78-355). Despitehigh yielding, stable expression of all three constructs, only
PKG78-355 yielded diffraction-quality crystals.
Overall Fold of PKG Ia78-355
Crystals grew in the C2 space group with two molecules per
asymmetric unit. Superimposition of Ca atoms from the two
molecules sites gave an average root mean square deviation
(rmsd) of 0.882. Initial phases were attained by molecular
replacement using the CNB-A domain of PKA RIa (PDB ID
1RGS) as a search model. The structure was refined to 2.5 A˚
with working and free-R factor values of 0.22 and 0.28, respec-
tively (Table 1). Eachproteinmolecule in the asymmetric unit con-
tained 278 amino acids, 1 cAMP molecule, and 2 phosphates.
The overall fold presents both cGMP-binding domains of the
PKG Ia regulatory domain. cGMP-binding site A (residues
87–210) begins following a loop in the ‘‘hinge region,’’ for which
we see clear backbone density, followed by cGMP-binding site
B (residues 211–327) and a new helical subdomain we have
termed switch helix (SW, residues 328–355) (Figure 1B; see
Figure S1A, secondary structural elements, available online).
Both cGMP-binding sites exhibit classic features of the
conserved CNB fold (Figure 2A). A rigid eight-stranded b-barrel
sandwiches the phosphate binding cassette (PBC) between
b strands 6 and 7 which serves as a docking site for cNTs. The
b-barrel itself is flanked at the N terminus by the aN helix, the
310 loop, and the aA helix (collectively termed the N3A motif)
and C-terminally by the aB/aC helix. Surprisingly, the two CNB
domains presented in this structure have been captured in
different conformational states as is evident when comparing
helical elements between A- and B-domains (Figure 2B). Super-
imposition of the two cGMP-binding yields an rmsd of 1.124.
While the b-barrels superimpose well, there is variance in the
helical subdomains.ed
Table 1. Data Collection and Refinement Statistics
PKG Ia78-355
Data collection
Space group C2
Cell dimensions (A˚)
A 180.2
B 66.0
C 81.6
b () 113.8
No. of molecule per asymmetrical unit 2
Resolution (A˚) 2.50
Rmerge 0.085 (0.52)
Completeness (%) 97.9 (93.5)
I/sigma 18.7 (1.9)
No. reflections 32166
Refinement
Resolution (A˚) 50.0–2.50
Rwork/Rfree (%) 22.1/27.7
No. of protein residues 556
No. of ligands/ions 4
No. of water molecules 207
Rmsd
Bond lengths (A˚) 0.008
Bond angles () 1.4
Ramachandran angles (%)
Most favored 83.3
Disallowed None
Values in parentheses are for highest-resolution shell.
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Crystal Structure of PKG Regulatory DomainThe two cGMP-binding sites are separated by an elongated
B/C helix at the end of the A-domain (Figure 2A). This creates a
dumbbell-like topology between the two CNB domains and
resembles the conformation adopted by regulatory subunits of
PKA when bound to the catalytic subunits in the holoenzymeFigure 2. Topology of the cGMP-Binding Domains
(A) Overall fold of the tandem cGMP binding domains shown as cartoon represe
(B) Overlay of cGMP-A (teal) with cGMP-B (white). RMSD = 1.214 for Camolecules
Structure 19, 1317–13conformation (Kim et al., 2007; Wu et al., 2007). A kink in the C
helix in the middle of this cleft is a likely point at which the two
CNB domains undergo cGMP-mediated structural rearrange-
ments. Residues in this kink are clearly solvent exposed (Fig-
ure 1B; Figure S1A) and proteolysis at Arg202 readily occurs in
the absence of cGMP (Chu et al., 1997; Scholten et al., 2007).
Incubation with cGMP induces conformational changes that
prevent such proteolysis. Furthermore, cGMP binding increases
solvent protection in this region (Alverdi et al., 2008) further sug-
gesting that the A-domain C helix may be the center of cGMP-
induced conformational changes in the regulatory domain.
The extended conformation of PKG78-355 does not appear to
allow direct communication between the A- and B-domains.
This suggests that the structural determinants mediating coop-
erative binding of cGMP are not contributed by the core of the
regulatory domain. In support of this finding, previous studies
have demonstrated a loss of cooperativity upon deletion of
regions outside the cGMP-binding domains (Dostmann et al.,
1996; Heil et al., 1987). Moreover, in PKA holoenzyme structures
of both type Ia (Kim et al., 2007) and IIa (Wu et al., 2007) the cata-
lytic subunit docks to the cleft created by the extended topology
of the CNB domains in the regulatory subunits. Residue Gln78,
just C-terminal to the AI domain in PKG, is positioned in the
center of the two cGMP-binding sites (Figure 1B), which is where
the N terminus of PKG interacts with the catalytic core of the
enzyme via the AI domain (Heil et al., 1987; Hofmann et al.,
2009). While the precise docking mechanism may differ in the
PKG holoenzyme, the catalytic domain is likely to sit in this cleft
and participate in crosstalk between the two cGMP-binding sites
similar to the architectural arrangements observed in PKA.The A-Domain Is cAMP Bound
The docking of cNTs to a CNB domain is made possible by the
conserved and mobile motif of the PBC (Figure 3A) (Diller et al.,
2001; McKay et al., 1982; Su et al., 1995). This short, 14 residue
helix-turn contains residues that coordinate the ribose-phos-
phate moiety and allows for the preferential binding of cAMP
versus cGMP. Invariantly, all CNB domains from cNT-regulatedntation with secondary structural elements labeled (switch helix not shown).
. PBC from cGMP-A: red, C117-C195 disulfide bond: yellow. See also Figure S1.
27, September 7, 2011 ª2011 Elsevier Ltd All rights reserved 1319
Figure 3. Features of the A-Domain
(A) Sequence alignment for PBCs from PKA and PKG Ia isoforms. Threonine residues in the 13 position of PKG PBCs are highlighted yellow.
(B) Composite omit map generated for the cNT binding sites of both A-domains contoured to 1.5 s. syn-cAMP is modeled into the positive density.
(C) Specific interactions between the sugar-phosphate moiety of cAMP and residues from the PBC. The 20-hydroxyl hydrogen bonds with Glu167, the equatorial
oxygen of the phosphate group interacts with Arg176, and the apical oxygen contacts both the side-chain hydroxyl and backbone amino groups of Thr177. The
backbone carbonyl of Leu138 bridges communication from the guanidinium group of Arg176 through the b2-b3 loop to Arg
193 in the B helix.
(D) A hydrophobic face accommodates the solvent-exposed nucleobase.
(E) Schematic of cNT binding to the A-domain of PKG Ia78-355 with cGMPmodeled in place of the observed cAMP. Specific hydrogen bond contacts are shown as
dotted lines. Interactions coming from backbone amide (blue) and carbonyl (red) are highlighted, whereas side-chain interactions are shown from the center of the
circled residue. Hydrophobic interactions with the cNT are shown as boxed residues. See also Figure S1.
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Crystal Structure of PKG Regulatory Domainprotein kinases have a Glu in the 3 position and an Arg in the 12
position, which hydrogen bonds with the 20OH and equatorial
oxygen, respectively. Unique to PKG is a Thr or Ser in the 13
position of the PBC, which has been predicted to provide spec-
ificity for cGMPby providing a hydrogen bond potential with both1320 Structure 19, 1317–1327, September 7, 2011 ª2011 Elsevier Ltthe 2-NH2 and apical oxygen of cGMP (Shabb and Corbin, 1992;
Weber et al., 1989). PKA contains an Ala in the 13-position and
mutation of this residue to a Thr produces a PKA mutant that
no longer discriminates between cAMP and cGMP (Shabb
et al., 1990).d All rights reserved
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Crystal Structure of PKG Regulatory DomainTo assess the occupancy of PBCs in the PKG78-355 structure,
initial phases from the molecular replacement solution were
used to generate a simulated annealing composite omit map.
In order to minimize model bias, side chains for the invariant
Glu, Arg, and Thr residues were omitted in each PBC. A strong
positive peak was observed in the A-domain which resembled
a cyclic-30,50-nucleotide monophosphate containing a purine
moiety in the syn configuration (Figure 3B), while the B-domain
appeared cNT-free. While electron density at the 20OH of the
ribose and the 6 position of the purine was evident, we could
not attribute the 6 position density to being either a keto/enol
or amino group. However, there was no density extending from
the 2 position where the 2-amino group of cGMP should reside.
This was a clear indication that the cNT occupying the A-domain
was syn-oriented cAMP. HPLC analysis and UV-spectroscopy
confirmed the presence of cAMP and the absence of cGMP
(see methods).
The primary interactionsmadewith the cyclic nucleotide come
from residues buried within the PBC. Specific contacts aremade
byGlu167, Arg176, and Thr177 (Figure 3C). Glu167 forms a hydrogen
bond with the 20OH of the ribose and Arg176 docks the equatorial
oxygen of the phosphate. Thr177 hydrogen bonds with the apical
oxygen of the phosphate group with both side-chain hydroxyl
and backbone amino groups. Modeling of syn-oriented cGMP
into the A-domain maintains these same contacts and shows
that the 2-amino group is primed to interact with the Thr177
side-chain hydroxyl. The Glu and Arg contacts are similar to
those used by the cAMP-PKA interaction and the previously
predicted interactions with Thr177 are confirmed (Shabb et al.,
1991; Weber et al., 1989). A schematic summary of these
specific interactions with cGMP modeled into the A-domain is
presented in Figure 3E.
As has been described for other CNB domain structures, cNT
docking to the PBC is stabilized by a capping mechanism that
sandwiches the nucleotide base between hydrophobic surface
on the b-barrel, and a hydrophobic cap that moves into place
upon cNT-induced structural rearrangements of the protein
(Berman et al., 2005; Das et al., 2007). In the PKG78-355 structure,
the backside of the adenine ring is flanked by an array of
hydrophobic contacts with no obvious hydrogen bond donor
or acceptor potentials (Figures 3D). The identity of the specific
capping residue is not disclosed, however, because the two
CNB domains are in an extended, inactive conformation and
capping occurs only after ligand-mediated conformational
changes cause the two CNB domains to form a more compact
structure.
A second shell of regulation is provided by the b2-b3 loop. In
PKA this loop stabilizes the PBC arginine and provides allosteric
communication of binding events in the PBC to the B helix. In the
A-domain of PKG Ia, Arg176 is coordinated by a number of
conserved residues from the b2-b3 loop (Figure 3C). A hydro-
phobic interaction is made with Ile130, and the backbone
carbonyl and amide of Arg176 forms hydrogen bonds with the
Gly133 amide and Asp134 carbonyl, respectively. Furthermore,
the guanidinium group of Arg176 interacts with the carbonyl of
Leu138. Communication between the b2-b3 loop and the B helix
occurs via Arg193. The backbone amide of Arg193 is bridged by
the carbonyl of Ser137. This is where PKG differs from PKA.
The equivalent to Ser137 is Asp170 in the PKARIaA-domainwhichStructure 19, 1317–13hydrogen bonds not only with the backbone amide of the Arg in
the B helix, but also coordinates the guanidinium of the PBC Arg.
In doing so, a direct link from the PBC to the B helix hinge ismade
via the b2-b3 loop. In contrast, the PKG A-domain does not utilize
this same direct allosteric mechanism. This may be a critical
divergence in how these two cNT-regulated protein kinases
communicate binding events in their PBCs with the rest of the
molecule.
A Cys117-Cys195 Disulfide Bond Locks A and B Helices
in the A-Domain
The presence of disulfide bonds in PKG Ia have been reported
and an oxidation-induced mechanism of activation has been
proposed as complementary mechanism to cyclic nucleotide-
mediated regulation of kinase activity (Burgoyne et al., 2007;
Landgraf et al., 1991). PKG Ia contains 11 cysteine residues
(Takio et al., 1984), 5 of which have been suggested to contribute
to oxidation-induced activation. Cys42, just C-terminal of the
D/D domain forms an intermolecular disulfide bond with Cys42
from the opposing protomer in the holoenzyme assembly (Bur-
goyne et al., 2007). It has been suggested that H2O2-induced
oxidation of PKG Ia promotes kinase activation via a bridging
of these two cysteines. Additionally, exposure of PKG Ia to diva-
lent cations with positive redox potentials promotes enzyme
activation via disulfide bond formation between Cys117-Cys195
and/or Cys312-Cys518 (Landgraf et al., 1991). It was unclear,
however, whether Cys117-Cys195 or Cys312-Cys518 was exclu-
sively responsible for the observed oxidation-induced activation.
Despite the observations that cysteine oxidation can lead to
cGMP-independent activation of PKG Ia, no molecular mecha-
nism of activation has been proposed.
The PKG78-355 structure reveals a disulfide bridge between
Cys117 in the A helix and Cys195 at the start of the B helix (Fig-
ure 4A). Residues immediately C-terminal of these two cysteines
are solvent-exposed (Figure S1A), while a hydrophobic sheath
(Phe80, Ile114, Ile191, and Ile199) surrounds the disulfide bridge
and provides solvent protection (Figure 4B). In support of the
oxidation-induced activation of PKG Ia previously observed
(Landgraf et al., 1991), the recruitment of Phe80 to the hydro-
phobic sheath provides a hypothesis as to how the enzyme
might be activated in the absence of cGMP. The capping of
Cys117-Cys195 by Phe80 serves to order the loop that precedes
the N helix of the A-domain (Figure 4A). As the AI domain resides
just adjacent to Phe80, autoinhibition of the kinase may be
relieved through a movement of this loop to the hydrophobic
sheath. The reorganization of this region upon oxidation of
Cys117-Cys195 may disrupt the interaction between the AI and
catalytic center thereby releasing the kinase from a state of auto-
inhibition. Furthermore, the sulfhydryl group of Cys312 sits on b8
of the B-domain and points inward toward the center of the
b-barrel (not shown). It seems unlikely that Cys312 is capable of
forming a disulfide bridge with Cys518 from the activation loop
in the catalytic domain. Our structure supports the Cys117-
Cys195 disulfide bond as being involved in the metal-induced
activation of PKG Ia.
Mixed Configuration of the Two CNB Domains
The cNT-dependent structural dynamics of CNB domains are
well established (Berman et al., 2005; Kornev et al., 2008;27, September 7, 2011 ª2011 Elsevier Ltd All rights reserved 1321
Figure 4. Details of the Cys117-Cys195 Disulfide Bond
(A) The disulfide bridge in the A-domain between Cys117 and Cys195 (yellow)
covalently links the A helix to the B helix. 2Fo-Fc electron density contoured to
1.6s is shown for the loop preceding the N helix and the disulfide bond.
(B) Side view of the hydrophobic sheath (gray) surrounding the disulfide bond
(yellow).
Figure 5. Comparative Overlay of Helical Subdomains for PKG and
PKA CNB Domains
(A) Structural overlay of PKG A-domain (teal) with PKA A-domain (gray) from
the unliganded, holoenzyme structure (left, 2QCS) and the cAMP-bound
form (right, 1RGS).
(B) Structural overlay of PKG B-domain (blue) with PKA B-domain (gray) from
the unliganded, holoenzyme structure (left, 2QCS) and the cAMP-bound form
(right, 1RGS).
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Crystal Structure of PKG Regulatory DomainRehmann et al., 2007). While the b-barrel does not appear to
undergo significant conformational changes upon cNT binding,
the a-helical subdomain moves In and Out relative to the barrel
(Table 2). Ligand association with the PBC initiates these struc-
tural changes as several residuesmake specific interactions with
the nucleotide and close the PBC. This structural change is
communicated through hydrophobic residues to the N3A motif
and B/C helix. As a result, an extended B/C helix forms a hinge
and closes inward toward the b-barrel. This rearrangement is
accompanied by an outward shift of the N3Amotif. In PKA, these
cNT-induced conformational changes bring the two CNB
domains closer together, which is then stabilized by the associ-
ation of a hydrophobic capping residue with the nucleotide base.
Although there is sequence and spatial variability as to the iden-
tity of the cap that secures the nucleotide base to the b-barrel,
this allosteric mechanism is present in all CNB domain structures
described to date.Table 2. Summary of the Different Positions for Each Helical
Component of CNB Domains from PKA RIa and the PKG78-355
Structure
CNB Domain state PBC N3A Motif B/C Helix
PKA RIa:Ca apo OPEN IN OUT
PKA RIa:cAMP cNT bound CLOSED OUT IN
PKG-A Transition CLOSED IN OUT
PKG-B Transition OPEN OUT OUT
1322 Structure 19, 1317–1327, September 7, 2011 ª2011 Elsevier LtThe two CNB domains presented here are in a mixed, hybrid
configuration, with helical elements in both apo and cNT bound
orientations (Table 2). As only the high affinity A-domain is cNT
bound, the A-domain PBC is closed, relative to that of the
B-domain (Figure 2B). However, the subsequent conformational
changes inherent to CNB domains are not observed. An overlay
of the CNB domains from PKG and PKA indicate that the overall
fold is conserved, but positional differences in the helical subdo-
main evince the hybrid nature of this PKG structure (Figures 5A
and 5B). The B/C helix of the A-domain is clearly extended and
the N3A motif is In, representative of a CNB domain in the apo,
unliganded state rather than a cNT-bound conformation (Kornev
et al., 2008; Figure 5A). Despite the A-domain PBC being occu-
pied by cAMP, allosteric communication of this binding event
with the rest of the domain is severed. Interestingly, the
Cys117-Cys195 disulfide bond provides a major structural deter-
minant for this stable transition state. The covalent bridging of
the A helix to the B helix prevents the B/C helix from closing
upon cNT binding to the PBC. In turn, the N3A motif cannot
move out from the b-barrel (Figure 5A, arrow). This disulfide
bond therefore uncouples communication of allosteric events
in the A-domain from being transmitted to the B-domain.
The B-domain of this PKG structure is similarly locked in a
hybrid conformation. This CNB domain is cNT free, thus the
unbound PBC isOpen andmaintains an extended B/C helix (Fig-
ure 5B). However, the N3A motif is also Out, an orientationd All rights reserved
Figure 6. Dimeric View of PKG78-355 Protomers
(A) Ribbon diagram of two PKG78-355 protomers as
observed in the asymmetric unit. Color coding is same as
in Figure 2A.
(B) ‘‘Front’’ and Top’’ views of surface representation of
the PKG78-355 dimer to illustrate the crossing of switch
helices. See also Figure S2.
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Crystal Structure of PKG Regulatory Domainreminiscent of a cNT-bound state (Kornev et al., 2008). The
B-domain N3A motif is stabilized in the Out position by a set of
hydrophobic residues originating from the C-terminal end of
the SW in the other molecule in the asymmetric unit. The two
symmetry mates are related by noncrystallographic symmetry
and this interaction promotes a previously uncharacterized
docking interface between PKG Ia protomers, which is
described in detail below.
PKG78-355 Protomers Interact via Their Switch Helices
Remarkably, the PKG78-355 crystal structure forms a symmetry-
related dimer through the formation of an interface between
the SW and the opposing B-domain (Figures 6A and 6B). It is
well established that PKG assembles into parallel homodimers,
an assembly mediated by leucine zipper motifs at the immediate
N termini. The structure presented here provides the first
evidence for intermolecular communication at sites distal to
the classical N-terminal D/D domain. The SW extends from the
B-domain and residues at the C terminus of each SW interact
with an open hydrophobic network in the B-domain of the
opposing protomer (Figures 7A and 7B). Hydrophobic ‘‘knobs’’
at the end of the SW (residues 350–354) stabilize the open N3A
motif in the B-domain of the neighboring protomer. Side chains
from Phe350, Phe351, and Leu354 fill the void created by an exten-Structure 19, 1317–1327, September 7,sive hydrophobic ‘‘nest’’ (Figures 7A and 7B).
The eight residues that comprise the nest
(Phe221, Leu224, Leu232, Trp288, Gln295, Phe320,
Ile324, Leu327) are noncontiguous and recruited
from the entire B-domain (Figure S1A). This
knob-nest interface is further strengthened by
Asn353, the only polar residue at the end of the
SW, which forms a hydrogen bond with the
backbone carbonyl of Thr220 in the 310 loop of
the B-domain (Figures 7A and 7B). Formation
of this dimeric assembly protects 2740 A˚2 of
surface area, and has a free energy (DG) of
15.8 kcal/mol required for dissociation, an indi-
cation that this arrangement is thermodynami-
cally stable in solution. Native PAGE analysis
of PKG78-355 in solution displays a small popula-
tion of dimeric protein (Figure S2A). Similarly,
the migration of crystalline PKG78-355 is consis-
tent with a dimer (Figure S2B).
Our initial DxMS studies on PKG78-355 offered
further validation of the significance of this
knob-nest interface. Analysis of peptide frag-
ments from the SW indicated that the C-terminal
residues containing the hydrophobic knobs and
Asn353 had a slower rate of deuterium exchangecompared with residues in the more solvent-exposed region of
this helix. This finding suggested that the very C terminus of
the SW is protected in solution and that the knob-nest interaction
may serve as the focal point of interchain communication
between PKG protomers. Interestingly, the knob residues
appear to be unique to PKG I isoforms, as PKG II has a large
amino acid insertion at the site of the SW (see sequence align-
ment, Figure S1A). However, hydrophobic residues at the equiv-
alent nest positions are conserved in both PKG I and II isoforms.
Mutational Disruption of the Knob-Nest Interface
in Full-Length PKG Ia Decreases the Activation
Constant and Suggests a Tethering Mechanism
for the Catalytic Domain
The functional relevance of the knob-nest interface was probed
by Alanine scanning mutagenesis of the SW knob residues in
full-length PKG Ia containing both the N-terminal D/D and the
catalytic domains. Extracts from HEK293 cells expressing
wild-type and mutant PKG Ia were examined for phosphoryl
transfer activity. Removal of the specific hydrogen bond
provided by Asn353 (N353A) resulted in a significantly decreased
activation constant (Figure 7C and Table 3). The entire knob-
nest interface was disrupted by a quadruple mutation wherein
all hydrophobic knob residues in addition to the specific2011 ª2011 Elsevier Ltd All rights reserved 1323
Figure 7. Structural Details of the Switch Helix-
Mediated Dimer Interface
(A) ‘‘Top’’ view of switch helices (SW) and their assem-
blage with the neighboring B-domain: hydrophobic knobs
at the end of the SW (blue), residues that comprise a
hydrophobic nest in the B-domain (orange).
(B) Details of the knob-nest assembly that mediates
PKG78-355 dimerization. The switch helix (white), and
helical features from the neighboring B-domain (gray) are
represented as ribbons.
(C) Kinetic Analysis of WT PKG Ia (black) and SW knob
mutants F350A, F351A, L354A (gray), N353A (red), and F350A,
F351A, N353A, L354A (blue). See also Figures S1 and S2.
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Neutralization of these interactions further reduced the activa-
tion constant greater than 4-fold (Figure 7C and Table 3). Addi-
tionally, this mutant displayed a loss of cooperativity (nH). While
we were unable to calculate absolute basal and Vmax values,
the relative changes in KA, combined with the observed
decrease in Hill coefficient, illustrates the importance of the
knob-nest interface in maintaining the kinetic fidelity of PKG
Ia. In the context of full-length PKG Ia, the SW seems to act1324 Structure 19, 1317–1327, September 7, 2011 ª2011 Elsevier Ltd All rights reservas a tether for the catalytic domain, disruption
of which causes the kinase to be more easily
activated.
Direct communication between regulatory
and catalytic elements is not without precedent
in AGC kinases. In PKA, there are at least
four major sites of contact between the R and
C subunits, with CNB domain A providing the
largest docking surface for the C subunit
(Boettcher et al., 2011; Kim et al., 2007). Like-
wise, in PKC bII, the conserved NFD motif in
the catalytic domain is clampedby thediacylgly-
cerol-binding C1B domain until fully activated
(Leonard et al., 2011). While these interactions
highlight the diversity of interdomain comple-
mentarity among AGC kinase family members,
they also demonstrate clear commonalities in
their mechanisms of regulation.
This crystal structure provides the first atomic
view of PKG and provides a new platform for
understanding the allosteric regulation of the
holoenzyme complex. The overall fold of
PKG78-355 is surprising, in that a previously un-
characterized allosteric interface promotes a
novel means of communication between
PKG78-355 protomers wherein the catalytic
domain can be tethered between inactive and
active states. The crossing of switch helices
between protomers (Figure 6B) suggests that
the catalytic domain from one protomer is regu-
lated inpart by the regulatorydomainof theother
protomer. A complete understanding of PKG
structural dynamics will undoubtedly require
additional studies, however this new structurepresents crucial details into the long sought after mechanism of
allosteric PKG activation.
EXPERIMENTAL PROCEDURES
Bacterial Protein Expression and Purification
DNA for bovine PKG Ia encoding amino acids Q78-K355 was amplified by PCR
using the primers 50-CGGGATCCATGCAGGCATTCCGGAAGTTC-30 (sense)
and 50-GGAATTCCTACTACTTCAGGTTGGCGAAG-30 (antisense). The PCR
product was digested with BamHI and EcoRI and ligated into pRSET-Aed
Table 3. Summary of Kinetic Analysis from Figure 7C
Mutation KA (nM) nH
Fold
Activation
WT (n = 12) 67 ± 2 1.7 ± 0.09 11.0
F350A/F351A/L354A (n = 4) 70 ± 5 1.6 ± 0.06 12.3
N353A (n = 9) 57 ± 1 1.7 ± 0.06 5.9
F350A/F351A/N353A/L354A (n = 10) 15.3 ± 1.7 0.8 ± 0.09 3.1
Activation constants (KA) and Hill coefficients (nH) are presented for WT
PKG Ia and SW knob mutants. A statistically significant difference in KA
was noted for both the N353A and F350A/F351A/N353A/L354A mutants
(p < 0.001) compared with WT PKG Ia.
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Crystal Structure of PKG Regulatory Domain(Invitrogen) in frame with the N-terminal 6x-His tag. The plasmid was trans-
formed into E. coli BL21 and 5 ml starter cultures in LB were allowed to
grow to OD600 = 0.6 at 37
C, 300 RPM in the presence of 50 mg/ml Ampicillin.
One liter of Overnight Express (Novagen) media was inoculated 1:1000 in 4 liter
baffled flasks with the mid-log starter prep and grown at 25C, 300 RPM for
16–24 hr. Bacteria were harvested by centrifugation at 5K RPM for 10 min
at 4C, and pellets were stored at 80C. Pellets were resuspended in
5 ml/gram of 50 mM MES (pH 6.8), 100 mM NaCl, 5 mM MgCl2, 3 mM
TCEP, 5% glycerol (Buffer A) plus protease inhibitors. Cells were lysed at
1200 psi using a french pressure cell. Homogenates were clarified via centri-
fugation at 15K RPM for 90min at 4C and recombinant PKG Ia78-355 was puri-
fied from the supernatants on a Profinia protein purification system (Biorad)
using the native IMAC protocol. Eluted protein was subjected to three rounds
of dialysis in 2 liters of buffer A at 4C. A secondary purification step was
performed on an AKTAprime FPLC system by passing Ni2+-purified protein
over a HiLoad 16/60 Superdex 75 (GE Healthcare) gel filtration column and
collecting 1 ml fractions in Buffer A. Protein homogeneity was assessed via
SDS-PAGE and Coomassie staining. Desired fractions were pooled and
concentrated using 10K MWCO centrifugal concentrators (Sartorius). Typical
yields were 100 mg purified protein per liter of media.
Crystallization, Data Collection, and Model Refinement
Sparse matrix kits from Hampton Research were used to screen initial crystal
growth conditions. Crystals used for data collection were grown via hanging
drop vapor diffusion in 2.2 M (NH4)2SO4, 100 mM Tris (pH 8.0), 0.2% MPD
at a protein concentration of 25–35 mg/ml at 20C. Crystals were cryopro-
tected for 10–30 min in 2 M Li2SO4, 100 mM Tris (pH 8.0), 0.2%MPD and flash
frozen in liquid N2. 2.5 A˚ diffraction data were collected at beamline 8.2.1 at the
Advanced Light Source, Lawrence Berkeley National Laboratory. HKL2000
was used for data processing and scaling (Minor, 1997). Phases were gener-
ated with the program Phaser (McCoy et al., 2007) using the PKA regulatory
domain (PDB ID 1RGS) as a search model. Crystals grew in the C2 space
group with two molecules per asymmetric unit. The PKG Ia78-355 model was
manually built into electron density using the programs TURBO-FRODO
(Roussel and Cambillau, 1991) and Coot (Emsley et al., 2010). CNS (Bru¨nger
et al., 1998) was used for structure refinement. Publication-quality images
were generated using Pymol (The PyMOLMolecular Graphics System, Version
1.2r3pre, Schro¨dinger, LLC). Interface and assembly measurements of
symmetry mates were calculated using the protein interfaces, surfaces, and
assemblies service PISA at European Bioinformatics Institute (Krissinel and
Henrick, 2007).
Deuterium on Exchange
All deuterium exchange reactions were performed on ice, in a 4C cold room.
Exchange reactions were initiated by adding 6 ml buffered D2O to 2 ml purified
PKG Ia78-355 at 7 mg/ml. At the appropriate time points exchange was
quenched by adding 12 ml 1.6MGuHCl, 0.8% formic acid. In addition, nondeu-
terated samples were prepared by incubating the protein in bufferedH2O. Fully
deuterated sampleswere prepared by incubating the protein in D20 buffer con-
taining 1% formic acid overnight at room temperature. The samples were
frozen on dry ice and stored at 80C until analysis by mass spectrometry.
Samples were manually thawed on wet ice and immediately analyzed byStructure 19, 1317–13LC-MS. Procedures for pepsin digestion for DXMS have been described previ-
ously (Burns-Hamuro et al., 2005; Hamuro et al., 2004; Pantazatos et al., 2004;
Spraggon et al., 2004). Briefly, the samples were passed through an immobi-
lized pepsin column and the protease-generated peptides were collected on a
C18 HPLC column. The peptides were eluted from the C18 column and the
effluent was directed to a Thermo Finnigan LCQ electrospray ion trap type
mass spectrometer with data acquisition in either MS1 profile mode or data-
dependent MS2 mode. The pepsin-generated peptides from the MS/MS
data sets were identified using SEQUEST (Thermo Finnigan Inc.), followed
by analysis using customized DXMS data reduction software (Sierra Analytics
Inc., Modesto, CA). Corrections for back exchange were made through
measurement of loss of deuterium from fully deuterated samples. Deuterium
incorporation for each peptide was calculated using the methods of Zhang
and Smith (1993):
deuteration level ð%Þ=mðpÞ mðNÞ
mðFÞ mðNÞ3 100;
where m(P), m(N), and m(F) are the centroid value of the partially deuterated,
nondeuterated, and fully deuterated peptide, respectively. The experiments
were performed twice, and the reported results are the average of the two
experiments.Cyclic Nucleotide Analysis
To confirm the copurification of cAMP, purified PKG78-355 was incubated on
ice in a 1:1 ratio of acetonitrile. The extract was clarified via centrifugation at
4C and the supernatant was subjected to UV-spectroscopy. The extract
had a single peak with a lmax of 258 nm and lacked the characteristic cGMP
shoulder. The same extract was subjected to HPLC analysis using a Merck
Hitachi HPLC system comprising a L-2130 pump, a L-2400 UV detector,
a L-2350 column oven, and a L-2200 autosampler, and data were processed
with EZChrom Elite evaluation software (3.2.1). Isocratic runs were performed
at 30C on a RP-18 reversed phase silica column (250 3 4 mm, ODS A,YMC)
with 2.5% isopropanol and 25 mM triethylammonium formate buffer (pH 6.9)
with a flow of 1 ml/min at 255 nm.Mammalian Protein Expression
WT PKG Ia was cloned into pcDNA 3.1 using BamHI and EcoRI. Mutations
were made using QuickChange site-directed mutagenesis (Agilent Technolo-
gies, Santa Clara, CA) per manufacturer’s recommendations. HEK293 cells
grown in 10 cm dishes were transfected for 5 hr using Metafectene (Biontex,
San Diego, CA) at a ratio of 20 mg DNA per 60 ml lipid. Sixty hours after trans-
fection cells were harvested by scraping into PBS, 2 mM benzamidine-HCl,
200 mMEDTA. Protein concentration was determined by the Bradford method
and stocks were stored in 50% glycerol at 20C.Kinetic Analysis
Determination of activation constants was performed using a [g-32P]-ATP
transfer assay as previously reported (Ruth et al., 1991; Tegge et al., 1995).
Briefly, 0.5 mg of wild-type or mutant protein from PKG-transfected HEK293
cells was incubated in buffer with various concentration of cGMP in the
presence of [g-32P]-ATP and the PKG-specific peptide substrate TQAKRKK
SLAMA (Dostmann et al., 1999). Aliquots, spotted on P81 Whatman paper
were subjected to scintillation counting. All experiments were performed in
the presence of the PKA-specific inhibitor, PKI5-24 (70 nM) to suppress endog-
enous PKA activity. Mock-transfected cells did not show any activity.ACCESSION NUMBERS
Coordinates have been deposited in the Protein Data Bank with accession
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